Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

Amgen (AMGN) closed at $361.13 in the latest trading session, marking a -1.4% move from the prior day. This change lagged the S&P 500's daily gain of 0.25%. Meanwhile, the Dow experienced a rise of 0.

Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

In early March 2026, Amgen announced a US$2.52 per-share second-quarter dividend and joined the government-run TrumpRx ...

Amgen’s AMGN stock has risen almost 16% in a month. A lot of this price increase is due to strong third-quarter 2025 results, wherein both the top and bottom lines exceeded expectations. Amgen also ...

Why Amgen (AMGN) is on investors’ radar today Amgen (AMGN) is back in focus after recent share price moves, with the stock ...

Amgen reaches a fresh annual peak amid strong quarterly performance and renewed institutional accumulation. Major research firms revise price targets following operational outperformance and margin ...